Published in Microbiology on November 01, 2001
Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev (2004) 5.80
Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol (2004) 2.58
Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis (2009) 2.36
Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol (2002) 2.02
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Population diversity among Bordetella pertussis isolates, United States, 1935-2009. Emerg Infect Dis (2012) 1.45
Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One (2012) 1.35
Comparative genomics of prevaccination and modern Bordetella pertussis strains. BMC Genomics (2010) 1.33
Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest (2005) 1.32
Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc Biol Sci (2005) 1.24
Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun (2010) 1.17
Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol (2007) 1.14
Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med (2009) 1.11
Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol (2004) 1.10
Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect Immun (2006) 1.02
Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994. J Clin Microbiol (2003) 0.97
Integrating life history and cross-immunity into the evolutionary dynamics of pathogens. Proc Biol Sci (2006) 0.95
Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg Infect Dis (2012) 0.94
Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model. Clin Vaccine Immunol (2010) 0.93
Studies on Prn variation in the mouse model and comparison with epidemiological data. PLoS One (2011) 0.91
Genetic control of Bordetella pertussis infection: identification of susceptibility loci using recombinant congenic strains of mice. Infect Immun (2005) 0.90
Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen. Infect Immun (2004) 0.90
Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin. Infect Immun (2008) 0.89
Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy. Hum Immunol (2014) 0.88
Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling. Immunogenetics (2007) 0.87
Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice. Clin Vaccine Immunol (2007) 0.83
Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV). PLoS One (2010) 0.81
Comparative gene expression profiling in two congenic mouse strains following Bordetella pertussis infection. BMC Microbiol (2007) 0.81
Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE. Infect Immun (2004) 0.78
Multilocus Sequence Analysis of Housekeeping Genes and Antigenic Determinant Genes in Bordetella pertussis Strains Isolated in Korea. Osong Public Health Res Perspect (2011) 0.77
The Bordetella pertussis type III secretion system tip complex protein Bsp22 is not a protective antigen and fails to elicit serum antibody responses during infection of humans and mice. Infect Immun (2013) 0.77
New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates. Vaccines (Basel) (2015) 0.76
Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function. PLoS One (2015) 0.76
Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran. Int J Mol Cell Med (2015) 0.75
Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism. Eur J Clin Microbiol Infect Dis (1996) 4.87
Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J (1995) 3.46
Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun (1991) 3.11
Cloning, mapping and expression of the genetic determinant that encodes for the K88ab antigen. Nucleic Acids Res (1979) 2.80
Discrimination of epidemic and nonepidemic methicillin-resistant Staphylococcus aureus strains on the basis of protein A gene polymorphism. J Clin Microbiol (1994) 2.72
Phase variation of H. influenzae fimbriae: transcriptional control of two divergent genes through a variable combined promoter region. Cell (1993) 2.53
Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J (1990) 2.53
Organization and expression of genes involved in the production of the K88ab antigen. Infect Immun (1981) 2.34
Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis (1997) 2.32
Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis (2000) 2.29
Molecular biology of fimbriae of enterotoxigenic Escherichia coli. Curr Top Microbiol Immunol (1985) 2.26
Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis (2010) 2.26
Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J Infect Dis (1999) 2.25
Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology (1999) 2.09
Regulation and structure of an Escherichia coli gene coding for an outer membrane protein involved in export of K88ab fimbrial subunits. Nucleic Acids Res (1986) 1.96
Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol (1993) 1.95
DNA fingerprinting of Vibrio cholerae strains with a novel insertion sequence element: a tool to identify epidemic strains. J Clin Microbiol (1996) 1.87
The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. Vaccine (1998) 1.86
Construction and characterization of mutants impaired in the biosynthesis of the K88ab antigen. J Bacteriol (1982) 1.82
Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology (1996) 1.79
Identification and characterization of precursors in the biosynthesis of the K88ab fimbria of Escherichia coli. J Bacteriol (1983) 1.76
Cloning and expression in Escherichia coli of Haemophilus influenzae fimbrial genes establishes adherence to oropharyngeal epithelial cells. EMBO J (1989) 1.66
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine (2007) 1.66
The fimbrial adhesins of Escherichia coli. Adv Microb Physiol (1986) 1.63
K88ab gene of Escherichia coli encodes a fimbria-like protein distinct from the K88ab fimbrial adhesin. J Bacteriol (1984) 1.62
The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship. Int J Syst Bacteriol (1996) 1.58
The fimbrial gene cluster of Haemophilus influenzae type b. Mol Microbiol (1994) 1.58
What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis (2010) 1.58
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Characterization of a Bordetella pertussis fimbrial gene cluster which is located directly downstream of the filamentous haemagglutinin gene. Mol Microbiol (1992) 1.48
Structure and function of periplasmic chaperone-like proteins involved in the biosynthesis of K88 and K99 fimbriae in enterotoxigenic Escherichia coli. Mol Microbiol (1991) 1.43
Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol (2005) 1.41
Characterization of IS1001, an insertion sequence element of Bordetella parapertussis. J Bacteriol (1993) 1.39
Mutational analysis of the Bordetella pertussis fim/fha gene cluster: identification of a gene with sequence similarities to haemolysin accessory genes involved in export of FHA. Mol Microbiol (1994) 1.38
Genetic organization and functional analysis of the otn DNA essential for cell-wall polysaccharide synthesis in Vibrio cholerae O139. Mol Microbiol (1996) 1.30
Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect Immun (1999) 1.27
Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect Immun (1994) 1.27
Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis. Antimicrob Agents Chemother (1996) 1.23
Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits. J Infect Dis (2000) 1.22
Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from The Netherlands. J Antimicrob Chemother (1997) 1.21
Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect Immun (2001) 1.19
A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b. Clin Diagn Lab Immunol (1998) 1.18
Seasonal patterns in time series of pertussis. Epidemiol Infect (2009) 1.18
The psychrotrophic bacterium Yersinia enterocolitica requires expression of pnp, the gene for polynucleotide phosphorylase, for growth at low temperature (5 degrees C). Mol Microbiol (1998) 1.17
(1----5)-linked beta-D-galactofuranosides are immunodominant in extracellular polysaccharides of Penicillium and Aspergillus species. Mol Immunol (1988) 1.11
The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars. Infect Immun (1996) 1.10
Establishment of a European network for the surveillance of Mycobacterium tuberculosis, MRSA and penicillin-resistant pneumococci. J Antimicrob Chemother (1996) 1.10
Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect (2004) 1.10
Isolation of a putative fimbrial adhesin from Bordetella pertussis and the identification of its gene. Mol Microbiol (1993) 1.09
Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes. J Bacteriol (2006) 1.09
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma. J Immunother (2000) 1.09
Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect Immun (1997) 1.09
Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract. Infect Immun (1997) 1.08
Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine (2006) 1.06
Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer. Mol Microbiol (2000) 1.06
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin? J Bacteriol (1999) 1.06
Identification of T cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis. J Exp Med (1992) 1.06
A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains. Eur J Immunol (2000) 1.06
Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases. J Immunol (1995) 1.05
The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect (2000) 1.05
Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J Infect Dis (2001) 1.05
Identification of minor fimbrial subunits involved in biosynthesis of K88 fimbriae. J Bacteriol (1992) 1.04
Sequence variability of FrpB, a major iron-regulated outer-membrane protein in the pathogenic neisseriae. Microbiology (1996) 1.04
The seroepidemiology of measles in Western Europe. Epidemiol Infect (2001) 1.04
Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates. Infect Immun (1991) 1.04
Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods (2009) 1.03
Detection and identification of FaeC as a minor component of K88 fibrillae of Escherichia coli. Mol Microbiol (1989) 1.03
Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimD. J Infect Dis (1995) 1.02
Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect Immun (2006) 1.02
T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements. J Immunol (1991) 1.01
Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates. Infect Immun (1991) 1.00
Synthetic trimer and tetramer of 3-beta-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys. Infect Immun (1992) 1.00
Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J Virol (1993) 0.99
T-cell responses to outer membrane proteins of Neisseria meningitidis: comparative study of the Opa, Opc, and PorA proteins. Infect Immun (1996) 0.98
HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein. J Virol (2000) 0.97
Characterization of the fim2 and fim3 fimbrial subunit genes of Bordetella bronchiseptica: roles of Fim2 and Fim3 fimbriae and flagella in adhesion. Infect Immun (1996) 0.96
Contribution of the major and minor subunits to fimbria-mediated adherence of Haemophilus influenzae to human epithelial cells and erythrocytes. Infect Immun (1995) 0.94
Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro. J Virol (1988) 0.93
The seroepidemiology of rubella in western Europe. Epidemiol Infect (2000) 0.93
Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia. Epidemiol Infect (2007) 0.93
Characterization of fimbriae from Bacteroides fragilis. Microb Pathog (1987) 0.92
Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines. FEMS Immunol Med Microbiol (1997) 0.92
Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012. Eur J Clin Microbiol Infect Dis (2014) 0.91
Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens. Vaccine (2000) 0.91
Genetic control of Bordetella pertussis infection: identification of susceptibility loci using recombinant congenic strains of mice. Infect Immun (2005) 0.90
Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis. Infect Immun (2003) 0.89
Solid-phase synthesis and applications of N-(S-acetylmercaptoacetyl) peptides. Anal Biochem (1990) 0.89
European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays. Vaccine (2000) 0.89
Excretion of proteins by gram-negative bacteria: export of bacteriocins and fimbrial proteins by Escherichia coli. Antonie Van Leeuwenhoek (1984) 0.88
Second generation meningococcal OMP-LPS vaccines. NIPH Ann (1991) 0.87
Simultaneous multiple synthesis and selective conjugation of cyclized peptides derived from a surface loop of a meningococcal class 1 outer membrane protein. Int J Pept Protein Res (1994) 0.87
Construction and analysis of a Vibrio cholerae delta-aminolevulinic acid auxotroph which confers protective immunity in a rabbit model. Infect Immun (1992) 0.86
Sero-epidemiology of mumps in western Europe. Epidemiol Infect (2003) 0.86
[Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003]. Ned Tijdschr Geneeskd (2005) 0.86
Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR. Clin Microbiol Infect (2012) 0.85
Intraocular T cells of patients with herpes simplex virus (HSV)-induced acute retinal necrosis recognize HSV tegument proteins VP11/12 and VP13/14. J Infect Dis (2000) 0.84
Bordetella bronchiseptica expresses the fimbrial structural subunit gene fimA. J Bacteriol (1997) 0.84
Distribution of Lys-gamma 2-melanocyte-stimulating hormone- (Lys-gamma 2-MSH)-like immunoreactivity in neuronal elements in the brain and peripheral tissues of the rat. Brain Res (1996) 0.84